Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort
Mukesh P SinghHorsefair Practice Group, Sandy Lane Health Centre, Rugeley, UKBackground: Once-daily long-acting β2-agonists (LABAs) are an important treatment option, either alone or in combination with other inhaled long-acting bronchodilators in the management of chronic obstructive pulmo...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-12-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/nbspindacaterol-therapy-in-moderate-to-severe-chronic-obstructive-pulm-a15229 |